Skip to main content
Erschienen in: Hernia 5/2006

01.10.2006 | Original Article

Ventral herniorrhaphy: experience with two different biosynthetic mesh materials, Surgisis and Alloderm

verfasst von: A. Gupta, K. Zahriya, P. L. Mullens, S. Salmassi, A. Keshishian

Erschienen in: Hernia | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to compare the efficacy and the complications associated with the use of two new bioactive meshes, Surgisis Gold 8-ply mesh, a product obtained by the processing of porcine small intestine sub-mucosa (Cook Surgical, Bloomington, IN, USA), and Alloderm, processed cadaveric human acellular dermis (Life Cell Corporation, Branchburg, NJ, USA), for ventral herniorrhaphy.

Background

Ventral hernia repair in potentially contaminated or potentially infected fields limit the use of synthetic mesh products. In this scenario, biosynthetic mesh products that are absorbed and/or replaced with the body’s own tissue reduce the incidence of post-operative chronic wound complications (Franklin et al. in Hernia 8(3):186–189, 2004; Franklin et al. in Hernia 6(4):171–174, 2002; Hirsch in J Am Coll Surg 198(2):324–328, 2004; Holton et al. in J Long Term Eff Med Implants 15(5):547–558, 2005; Buinewicz and Rosen in Ann Plast Surg 52(2):188–194, 2004). Rapid revascularization, repopulation, and remodeling of the matrix occur on contact with the patient’s own tissue. Only limited, and mostly preliminary data, is available on the use of these types of mesh and concerning the potential complications associated with the use of these types of meshes. We publish our experience with the use of these mesh products, along with their associated complications. Furthermore, we have also provided suggestions for improvements in the mesh designs.

Methods

Between June 2002 and March 2005, 74 patients underwent ventral hernia repair using biosynthetic or natural tissue mesh. The first 41 procedures were performed using Surgisis Gold 8-ply mesh formed from porcine small intestine sub-mucosa, and the remaining 33 patients had ventral hernia repair with Alloderm. The patients had their first follow-up 7–10 days after discharge from the hospital. They were again seen at 6 weeks, or, if needed, earlier, and, thereafter, as needed. Patients who reported any complications to the office were followed up immediately within 1–2 days. Any signs of wound infection, diastasis, hernia recurrence, changes in bowel habits, and seroma formation were evaluated.

Results

Non-perforated Surgisis mesh resulted in significant seroma formation in 10/11 patients. The seroma complication was reduced, but not eliminated, with the use of the perforated Surgisis mesh (3/30 patients). Explanted material revealed separated layers of un-incorporated middle layers of the 8-ply Surgisis mesh. Three of the patients had the mesh placed in a contaminated field with no resultant sequela, and there were no hernia recurrences. Patients also had a significant degree of discomfort and pain during the immediate post-operative period. The use of the Alloderm mesh resulted in eight hernia recurrences. Fifteen of the Alloderm patients (15/33) developed a diastasis or bulging at the repair site. Seroma formation was only a problem in two patients.

Conclusions

Seroma formation was a major problem with the non-perforated Surgisis mesh repair, as was the post-operative pain. On the other hand, post-operative diastasis and hernia recurrence were a major problem with the Alloderm mesh. Further design improvements are required in both forms of these new mesh products. Surgeons should be aware of these potential complications prior to the selection of either of these products and the patient should be informed and educated accordingly.
Literatur
1.
Zurück zum Zitat Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. New Engl J Med 343(6):392–398PubMedCrossRef Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. New Engl J Med 343(6):392–398PubMedCrossRef
2.
Zurück zum Zitat Sauerland S, Schmedt CG, Lein S, Leibl BJ, Bittner R (2005) Primary incisional hernia repair with or without polypropylene mesh: a report on 384 patients with 5-year follow-up. Langenbecks Arch Surg 390(5):408–412PubMedCrossRef Sauerland S, Schmedt CG, Lein S, Leibl BJ, Bittner R (2005) Primary incisional hernia repair with or without polypropylene mesh: a report on 384 patients with 5-year follow-up. Langenbecks Arch Surg 390(5):408–412PubMedCrossRef
3.
Zurück zum Zitat Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. J Ann Surg 240(4):578–583. Discussion, pp 583–585 Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. J Ann Surg 240(4):578–583. Discussion, pp 583–585
4.
Zurück zum Zitat Korenkov M, Sauerland S, Arndt M, Bograd L, Neugebauer EA, Troidl H (2002) Randomized clinical trial of suture repair, polypropylene mesh or autodermal hernioplasty for incisional hernia. Br J Surg 89(1):50–56PubMedCrossRef Korenkov M, Sauerland S, Arndt M, Bograd L, Neugebauer EA, Troidl H (2002) Randomized clinical trial of suture repair, polypropylene mesh or autodermal hernioplasty for incisional hernia. Br J Surg 89(1):50–56PubMedCrossRef
5.
Zurück zum Zitat Sugerman HJ, Kellum JM Jr, Reines HD, DeMaria EJ, Newsome HH, Lowry JW (1996) Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 171(1):80–84PubMedCrossRef Sugerman HJ, Kellum JM Jr, Reines HD, DeMaria EJ, Newsome HH, Lowry JW (1996) Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 171(1):80–84PubMedCrossRef
6.
Zurück zum Zitat Geisler DJ, Reilly JC, Vaughan SG, Glennon EJ, Kondylis PD (2003) Safety and outcome of use of nonabsorbable mesh for repair of fascial defects in the presence of open bowel. Dis Colon Rectum 46(8):1118–1123PubMedCrossRef Geisler DJ, Reilly JC, Vaughan SG, Glennon EJ, Kondylis PD (2003) Safety and outcome of use of nonabsorbable mesh for repair of fascial defects in the presence of open bowel. Dis Colon Rectum 46(8):1118–1123PubMedCrossRef
7.
Zurück zum Zitat Le H, Bender JS (2005) Retrofascial mesh repair of ventral incisional hernias. Am J Surg 189(3):373–375PubMedCrossRef Le H, Bender JS (2005) Retrofascial mesh repair of ventral incisional hernias. Am J Surg 189(3):373–375PubMedCrossRef
8.
Zurück zum Zitat Demir U, Mihmanli M, Coskun H, Dilege E, Kalyoncu A, Altinli E, Gunduz B, Yilmaz B (2005) Comparison of prosthetic materials in incisional hernia repair. Surg Today 35(3):223–227PubMedCrossRef Demir U, Mihmanli M, Coskun H, Dilege E, Kalyoncu A, Altinli E, Gunduz B, Yilmaz B (2005) Comparison of prosthetic materials in incisional hernia repair. Surg Today 35(3):223–227PubMedCrossRef
9.
Zurück zum Zitat Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Reader RH, Metzger DW (2001) Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 71(11):1631–1640PubMedCrossRef Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Reader RH, Metzger DW (2001) Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 71(11):1631–1640PubMedCrossRef
10.
Zurück zum Zitat Schultz DJ, Brasel KJ, Spinelli KS, Rasmussen J, Weigelt JA (2002) Porcine small intestine submucosa as a treatment for enterocutaneous fistulas. J Am Coll Surg 194(4):541–543PubMedCrossRef Schultz DJ, Brasel KJ, Spinelli KS, Rasmussen J, Weigelt JA (2002) Porcine small intestine submucosa as a treatment for enterocutaneous fistulas. J Am Coll Surg 194(4):541–543PubMedCrossRef
11.
Zurück zum Zitat Rosen M, Ponsky J, Petras R, Fanning A, Brody F, Duperier F (2002) Small intestinal submucosa as a bioscaffold for biliary tract regeneration. Surgery 132(3):480–486PubMedCrossRef Rosen M, Ponsky J, Petras R, Fanning A, Brody F, Duperier F (2002) Small intestinal submucosa as a bioscaffold for biliary tract regeneration. Surgery 132(3):480–486PubMedCrossRef
12.
Zurück zum Zitat Oelschlager BK, Barreca M, Chang L, Pellegrini CA (2003) The use of small intestine submucosa in the repair of paraesophageal hernias: initial observations of a new technique. Am J Surg 186(1):4–8PubMedCrossRef Oelschlager BK, Barreca M, Chang L, Pellegrini CA (2003) The use of small intestine submucosa in the repair of paraesophageal hernias: initial observations of a new technique. Am J Surg 186(1):4–8PubMedCrossRef
13.
Zurück zum Zitat Edelman DS (2002) Laparoscopic herniorrhaphy with porcine small intestinal submucosa: a preliminary study. J Soc Laparosc Surg 6(3):203–5 Edelman DS (2002) Laparoscopic herniorrhaphy with porcine small intestinal submucosa: a preliminary study. J Soc Laparosc Surg 6(3):203–5
14.
Zurück zum Zitat Franklin ME Jr, Gonzalez JJ Jr, Glass JL (2004) Use of porcine small intestinal submucosa as a prosthetic device for laparoscopic repair of hernias in contaminated fields: 2-year follow-up. Hernia 8(3):186–189PubMedCrossRef Franklin ME Jr, Gonzalez JJ Jr, Glass JL (2004) Use of porcine small intestinal submucosa as a prosthetic device for laparoscopic repair of hernias in contaminated fields: 2-year follow-up. Hernia 8(3):186–189PubMedCrossRef
15.
Zurück zum Zitat Franklin ME Jr, Gonzalez JJ Jr, Michaelson RP, Glass JL, Chock DA (2002) Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6(4):171–174PubMedCrossRef Franklin ME Jr, Gonzalez JJ Jr, Michaelson RP, Glass JL, Chock DA (2002) Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6(4):171–174PubMedCrossRef
16.
Zurück zum Zitat Menon NG, Rodriguez ED, Byrnes CK, Girotto JA, Goldberg NH, Silverman RP (2003) Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 50(5):523–527. Erratum in: Ann Plast Surg 51(2):228PubMedCrossRef Menon NG, Rodriguez ED, Byrnes CK, Girotto JA, Goldberg NH, Silverman RP (2003) Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 50(5):523–527. Erratum in: Ann Plast Surg 51(2):228PubMedCrossRef
17.
Zurück zum Zitat Eppley BL (2001) Experimental assessment of the revascularization of acellular human dermis for soft-tissue augmentation. Plast Reconstr Surg 107(3):757–762PubMedCrossRef Eppley BL (2001) Experimental assessment of the revascularization of acellular human dermis for soft-tissue augmentation. Plast Reconstr Surg 107(3):757–762PubMedCrossRef
18.
Zurück zum Zitat Holton LH 3rd, Kim D, Silverman RP, Rodriguez ED, Singh N, Goldberg NH (2005) Human acellular dermal matrix for repair of abdominal wall defects: review of clinical experience and experimental data. J Long Term Eff Med Implants 15(5):547–558PubMedCrossRef Holton LH 3rd, Kim D, Silverman RP, Rodriguez ED, Singh N, Goldberg NH (2005) Human acellular dermal matrix for repair of abdominal wall defects: review of clinical experience and experimental data. J Long Term Eff Med Implants 15(5):547–558PubMedCrossRef
19.
Zurück zum Zitat McDonald MD, Weiss CA (2005) Human acellular dermis for recurrent hernias. Contemp Surg 61(6):276–280 McDonald MD, Weiss CA (2005) Human acellular dermis for recurrent hernias. Contemp Surg 61(6):276–280
20.
Zurück zum Zitat Warren WL, Medary MB, Dureza CD, Bellotte JB, Flannagan PP, Oh MY, Fukushima T (2000) Dural repair using acellular human dermis: experience with 200 cases: technique assessment. Neurosurgery 46(6):1391–1396PubMedCrossRef Warren WL, Medary MB, Dureza CD, Bellotte JB, Flannagan PP, Oh MY, Fukushima T (2000) Dural repair using acellular human dermis: experience with 200 cases: technique assessment. Neurosurgery 46(6):1391–1396PubMedCrossRef
21.
Zurück zum Zitat Shorr N, Perry JD, Goldberg RA, Hoenig J, Shorr J (2000) The safety and applications of acellular human dermal allograft in ophthalmic plastic and reconstructive surgery: a preliminary report. Ophthalmic Plast Reconstr Surg 16(3):223–230CrossRef Shorr N, Perry JD, Goldberg RA, Hoenig J, Shorr J (2000) The safety and applications of acellular human dermal allograft in ophthalmic plastic and reconstructive surgery: a preliminary report. Ophthalmic Plast Reconstr Surg 16(3):223–230CrossRef
22.
Zurück zum Zitat Hirsch EF (2004) Repair of an abdominal wall defect after a salvage laparotomy for sepsis. J Am Coll Surg 198(2):324–328PubMedCrossRef Hirsch EF (2004) Repair of an abdominal wall defect after a salvage laparotomy for sepsis. J Am Coll Surg 198(2):324–328PubMedCrossRef
23.
Zurück zum Zitat Buinewicz B, Rosen B (2004) Acellular cadaveric dermis (AlloDerm): a new alternative for abdominal hernia repair. Ann Plast Surg 52(2):188–194PubMedCrossRef Buinewicz B, Rosen B (2004) Acellular cadaveric dermis (AlloDerm): a new alternative for abdominal hernia repair. Ann Plast Surg 52(2):188–194PubMedCrossRef
24.
Zurück zum Zitat Paajanen H, Hermunen H (2004) Long-term pain and recurrence after repair of ventral incisional hernias by open mesh: clinical and MRI study. Langenbecks Arch Surg 389(5):366–370PubMedCrossRef Paajanen H, Hermunen H (2004) Long-term pain and recurrence after repair of ventral incisional hernias by open mesh: clinical and MRI study. Langenbecks Arch Surg 389(5):366–370PubMedCrossRef
Metadaten
Titel
Ventral herniorrhaphy: experience with two different biosynthetic mesh materials, Surgisis and Alloderm
verfasst von
A. Gupta
K. Zahriya
P. L. Mullens
S. Salmassi
A. Keshishian
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Hernia / Ausgabe 5/2006
Print ISSN: 1265-4906
Elektronische ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-006-0130-2

Weitere Artikel der Ausgabe 5/2006

Hernia 5/2006 Zur Ausgabe

Personal Experience

Operation Hernia to Ghana

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.